Paradigm Biocapital Advisors LP - Sep 30, 2025 SCHEDULE 13G/A Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share
Symbol
URGN
Shares outstanding
46.8M shares
Disclosed Ownership
4.22M shares
Ownership
9%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:31 PM
Date of event
Sep 30, 2025
Previous filing
Aug 12, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 9% 4.22M 4.22M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 9% 4.22M 4.22M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 9% 4.22M 4.22M 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 8% 3.72M 3.72M 0 /s/ David K. Kim David K. Kim / Authorized Signatory